Efficacy, Safety, and Pharmacokinetics of Coadministered Diethylcarbamazine, Albendazole, and Ivermectin for Treatment of Bancroftian Filariasis. (Q40134519)

From Wikidata

Jump to navigation Jump to search

scientific article published on 20 October 2015

Language	Label	Description	Also known as
English	Efficacy, Safety, and Pharmacokinetics of Coadministered Diethylcarbamazine, Albendazole, and Ivermectin for Treatment of Bancroftian Filariasis.	scientific article published on 20 October 2015

Statements

scholarly article

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26486704%20AND%20SRC:MED&resulttype=core&format=json

27 February 2020

Efficacy, Safety, and Pharmacokinetics of Coadministered Diethylcarbamazine, Albendazole, and Ivermectin for Treatment of Bancroftian Filariasis (English)

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26486704%20AND%20SRC:MED&resulttype=core&format=json

27 February 2020

0 references

0 references

diethylcarbamazine

1 reference

based on heuristic

inferred from title

pharmacokinetics

1 reference

based on heuristic

inferred from title

Edward K Thomsen

1

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26486704%20AND%20SRC:MED&resulttype=core&format=json

27 February 2020

7

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26486704%20AND%20SRC:MED&resulttype=core&format=json

27 February 2020

10

object named as

James W Kazura

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26486704%20AND%20SRC:MED&resulttype=core&format=json

27 February 2020

8

object named as

Peter M Siba

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26486704%20AND%20SRC:MED&resulttype=core&format=json

27 February 2020

author name string

Nelly Sanuku

2

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26486704%20AND%20SRC:MED&resulttype=core&format=json

27 February 2020

Manasseh Baea

3

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26486704%20AND%20SRC:MED&resulttype=core&format=json

27 February 2020

Samson Satofan

4

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26486704%20AND%20SRC:MED&resulttype=core&format=json

27 February 2020

Elit Maki

5

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26486704%20AND%20SRC:MED&resulttype=core&format=json

27 February 2020

Bart Lombore

6

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26486704%20AND%20SRC:MED&resulttype=core&format=json

27 February 2020

Gary J Weil

9

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26486704%20AND%20SRC:MED&resulttype=core&format=json

27 February 2020

Lawrence L Fleckenstein

11

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26486704%20AND%20SRC:MED&resulttype=core&format=json

27 February 2020

Christopher L King

12

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26486704%20AND%20SRC:MED&resulttype=core&format=json

27 February 2020

language of work or name

0 references

publication date

20 October 2015

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26486704%20AND%20SRC:MED&resulttype=core&format=json

27 February 2020

Clinical Infectious Diseases

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26486704%20AND%20SRC:MED&resulttype=core&format=json

27 February 2020

62

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26486704%20AND%20SRC:MED&resulttype=core&format=json

27 February 2020

334-341

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26486704%20AND%20SRC:MED&resulttype=core&format=json

27 February 2020

3

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26486704%20AND%20SRC:MED&resulttype=core&format=json

27 February 2020

Lymphatic filariasis and onchocerciasis

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIV882

21 January 2018

The global programme to eliminate lymphatic filariasis: health impact after 8 years

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIV882

21 January 2018

Mass chemotherapy options to control lymphatic filariasis: a systematic review

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIV882

21 January 2018

Epidemiological modelling for monitoring and evaluation of lymphatic filariasis control

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIV882

21 January 2018

Long-term efficacy of single-dose combinations of albendazole, ivermectin and diethylcarbamazine for the treatment of bancroftian filariasis

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIV882

21 January 2018

Efficacy of single dose combinations of albendazole, ivermectin and diethylcarbamazine for the treatment of bancroftian filariasis.

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIV882

21 January 2018

Efficacy of albendazole and its combinations with ivermectin or diethylcarbamazine (DEC) in the treatment of Trichuris trichiura infections in Sri Lanka.

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIV882

21 January 2018

Mass treatment to eliminate filariasis in Papua New Guinea

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIV882

21 January 2018

Tolerability and efficacy of single-dose diethyl carbamazine (DEC) or ivermectin in the clearance of Wuchereria bancrofti microfilaraemia in Pondicherry, south India

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIV882

21 January 2018

The effect of single dose ivermectin alone or in combination with albendazole on Wuchereria bancrofti infection in primary school children in Tanzania

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIV882

21 January 2018

Liquid chromatography-mass spectrometry analysis of diethylcarbamazine in human plasma for clinical pharmacokinetic studies.

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIV882

21 January 2018

Liquid chromatographic assay of ivermectin in human plasma for application to clinical pharmacokinetic studies

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIV882

21 January 2018

HPLC assay for albendazole and metabolites in human plasma for clinical pharmacokinetic studies

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIV882

21 January 2018

Gas chromatographic assay of diethylcarbamazine in human plasma for application to clinical pharmacokinetic studies

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIV882

21 January 2018

Safety, tolerability, efficacy and plasma concentrations of diethylcarbamazine and albendazole co-administration in a field study in an area endemic for lymphatic filariasis in India

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIV882

21 January 2018

The pharmacokinetics, safety and tolerability of the co-administration of diethylcarbamazine and albendazole

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIV882

21 January 2018

Acute eosinophilic glomerulonephritis with Bancroftian filariasis

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIV882

21 January 2018

Immune complex glomerulonephritis and chronic anaerobic urinary infection—complications of filariasis

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIV882

21 January 2018

The co-administration of ivermectin and albendazole--safety, pharmacokinetics and efficacy against Onchocerca volvulus

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIV882

21 January 2018

Assessments of pharmacokinetic drug interactions and tolerability of albendazole, praziquantel and ivermectin combinations

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIV882

21 January 2018

Effect of gender in the disposition of albendazole metabolites in humans

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIV882

21 January 2018

A cell-based screen reveals that the albendazole metabolite, albendazole sulfone, targets Wolbachia

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIV882

21 January 2018

Identifiers

10.1093/CID/CIV882

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26486704%20AND%20SRC:MED&resulttype=core&format=json

27 February 2020

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26486704%20AND%20SRC:MED&resulttype=core&format=json

27 February 2020

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q40134519&oldid=1544023744"